The growth of Viagra and its impact on the pharmaceutical landscape presents a complicated question for shareholders. While the first sales statistics were impressive, the exclusivity has ended, leading to a flood of https://mayabhvo043644.amoblog.com/the-blue-pill-and-big-pharma-a-speculative-opportunity-63474499